Vitamin D and health: evolution, biologic functions, and recommended dietary intakes for vitamin D

MF Holick - Vitamin D: physiology, molecular biology, and clinical …, 2010 - Springer
Vitamin D deficiency is now being recognized as one of the most common medical
conditions worldwide. The consequences of vitamin D deficiency include poor bone …

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

G Jean, E Bresson, JC Terrat, T Vanel… - Nephrology Dialysis …, 2009 - academic.oup.com
Abstract Background. Vascular calcifications (VCs) are frequently observed in chronic
kidney disease (CKD) and haemodialysis (HD) patients. They have been associated with …

Association of activated vitamin D treatment and mortality in chronic kidney disease

CP Kovesdy, S Ahmadzadeh… - Archives of internal …, 2008 - jamanetwork.com
Background Treatment of secondary hyperparathyroidism (SHPT) with activated vitamin D
analogues is associated with better survival in patients receiving dialysis. It is unclear …

Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial

SA Jamal, DC Bauer, KE Ensrud… - Journal of Bone and …, 2007 - academic.oup.com
To determine if alendronate had differential effects on BMD and fracture by renal function,
we performed a secondary data analysis of women participating in the FIT. Alendronate …

Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES Study

M Naves-Diaz, J Passlick-Deetjen… - Nephrology Dialysis …, 2011 - academic.oup.com
Background. Mineral metabolism parameters may play a role in the survival of patients with
chronic kidney disease (CKD). Methods. In the CORES Study, we analysed the association …

Effect of aluminum accumulation on bone and cardiovascular risk in the current era

CEM Carbonara, NAV Roza, KRS Quadros, RA França… - PloS one, 2023 - journals.plos.org
Background The prevalence of aluminum (Al) intoxication has declined over the past 3
decades. However, different groups still report on the diagnosis of Al in bone. Prolonged and …

Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis

A Upadhyay, A Earley, JL Lamont… - Annals of internal …, 2012 - acpjournals.org
Background: Lipid-lowering therapy is not widely used in persons with chronic kidney
disease (CKD) despite a high burden of dyslipidemia and cardiovascular disease in this …

End stage renal disease in patients with Wilms tumor: results from the National Wilms Tumor Study Group and the United States Renal Data System

NE Breslow, AJ Collins, ML Ritchey… - The Journal of …, 2005 - auajournals.org
Purpose: We sought to assess accurately the full spectrum of end stage renal disease
(ESRD) in Wilms tumor survivors by combining the unique resources of the National Wilms …

Dialysis-related amyloidosis: challenges and solutions

R Scarpioni, M Ricardi, V Albertazzi… - … journal of nephrology …, 2016 - Taylor & Francis
Amyloidosis refers to the extracellular tissue deposition of fibrils composed of low-molecular-
weight subunits of a variety of proteins. These deposits may result in a wide range of clinical …

Microbiome in chronic kidney disease (CKD): an omics perspective

S Lohia, A Vlahou, J Zoidakis - Toxins, 2022 - mdpi.com
Chronic kidney disease (CKD) is predominant in 10% of the world's adult population, and is
increasingly considered a silent epidemic. Gut microbiota plays an essential role in …